Hatfield Jeffrey S. 4
4 · Vir Biotechnology, Inc. · Filed Jun 2, 2025
Insider Transaction Report
Form 4
Hatfield Jeffrey S.
Director
Transactions
- Award
Common Stock
2025-05-30+8,000→ 31,806 total - Award
Stock Option (Right to Buy)
2025-05-30+16,000→ 16,000 totalExercise: $4.94From: 2026-05-30Exp: 2035-05-29→ Common Stock (16,000 underlying)
Footnotes (3)
- [F1]Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.
- [F2]The RSUs will vest in full on May 30, 2026.
- [F3]The shares subject to the stock option will vest and become exercisable in full on May 30, 2026.